NCT06534983
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06534983
Title A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (MIUC) (IMCODE004)
Acronym IMCODE004
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | SWE | POL | NOR | ITA | GRC | GBR | ESP | DNK | DEU | CAN | AUS | ARG

Facility Status City State Zip Country Details
Memorial Sloan Kettering Cancer Center Basking Ridge Basking Ridge New Jersey 07920 United States Details
MSK Monmouth Middletown New Jersey 07748 United States Details
MSK Bergen Montvale New Jersey 07645 United States Details
MSK Commack Commack New York 11725 United States Details
MSK Westchester Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
MSK Nassau Uniondale New York 11553 United States Details
Fred Hutchinson Cancer Research Center Seattle Washington 98109 United States Details
University of Washington Medical Center Seattle Washington 98195 United States Details
Hospital Italiano Ciudad Autonoma Buenos Aires C1199ABB Argentina Details
Lyell McEwin Hospital Elizabeth Vale South Australia 5112 Australia Details
Jewish General Hospital Montreal Quebec H3T 1E2 Canada Details
McGill University Health Center Montreal Quebec H4A 3J1 Canada Details
Aalborg Universitetshospital Aalborg 9000 Denmark Details
Aarhus Universitetshospital Aarhus N 8200 Denmark Details
Herlev Hospital Herlev 2730 Denmark Details
Vivantes Klinikum Am Urban Berlin 10967 Germany Details
Uniklinikum Heidelberg Heidelberg 69120 Germany Details
Marien Hospital Herne Herne 44625 Germany Details
Klinikum Stuttgart - Katharinenhospital Stuttgart 70174 Germany Details
Attikon University General Hospital Athens 124 61 Greece Details
Theageneio Hospital Thessaloniki 546 39 Greece Details
A.O. Universitaria Ospedale Consorziale Policlinico Di Bari Bari Apulia 70124 Italy Details
IFO - Istituto Regina Elena Rome Lazio 00144 Italy Details
A.O. Universitaria S. Luigi Gonzaga Orbassano Piedmont 10043 Italy Details
A.O.U di Verona Policlinico G.B. Rossi Verona Veneto 37134 Italy Details
Akershus universitetssykehus Lørenskog 1474 Norway Details
Centrum Onkologii im. Prof. Franciszka ?ukaszczyka Bydgoszcz 85-796 Poland Details
Szpital Kliniczny Ministerstwa Spraw Wewn?trznych i Administracji z Warmi?sko-Mazurskim Centrum Onkologii w Olsztynie Olsztyn 10-228 Poland Details
AIDPORT Sp. z o. o. Skórzewo 60-185 Poland Details
Seoul National University Bundang Hospital Seongnam-si 463-707 South Korea Details
Seoul National University Hospital Seoul 03080 South Korea Details
Asan Medical Center Seoul 05505 South Korea Details
Samsung Medical Center Seoul 06351 South Korea Details
ICO L'Hospitalet L'Hospitalet de Llobregat Barcelona 08908 Spain Details
Vall d'Hebron Institute of Oncology (VHIO), Barcelona Sant Andreu de la Barca Barcelona 08740 Spain Details
Hospital Clinico San Carlos Madrid 28040 Spain Details
Hospital Universitario Virgen del Rocio Seville 41013 Spain Details
Hospital Clinico Universitario Lozano Blesa Zaragoza 50009 Spain Details
Sahlgrenska University Hospital Gothenburg 413 45 Sweden Details
Chang Gung Medical Foundation - Kaohsiung Kaohisung DUMMY_VALUE Taiwan Details
Royal Devon and Exeter Hospital Exeter EX2 5DW United Kingdom Details
Barts & London School of Med;Medical Oncology London EC1M 6BQ United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field